Biochemical basis of selenomethionine-mediated inhibition during 2-acetylaminofluorene-induced hepatocarcinogenesis in the rat

European Journal of Cancer Prevention

Volumn 5, Issue 6, 1996, Pages 455-463

  Mukherjee, B ^a   Sarkar, A ^a   Chatterjee, M ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

2 Acetylaminofluorene; Hepatic drug metabolizing enzymes; Hepatocarcinogenesis; Rat; Selenomethionine

Indexed keywords

CYTOCHROME B5; CYTOCHROME P450; N (2 FLUORENYL)ACETAMIDE; SELENOMETHIONINE; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; LIVER CARCINOGENESIS; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

2-ACETYLAMINOFLUORENE; ANIMALS; CARCINOGENS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; INCIDENCE; LIVER NEOPLASMS, EXPERIMENTAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SELENOMETHIONINE; WATER SUPPLY;

EID: 0030455680     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Anderson T, Pesonen M, Johansson C (1985). Differential induction of cytochrome P-450 dependent monoxygenase, epoxide hydroxylase, glutathione transferase and UDP-glucoronyl transferase activities in the liver of the rainbow trout by B-napthoflavone or clophen A 50. Biochem Pharmcol 34: 3309-14.
2. Beems RB (1986). Dietary selenium and benzo (a) pyrene induced respiratory tract tumors in hamsters. Carcinogenesis 7: 485-89.
3. Bergman K, Slanina P (1986). Effect of dietary selenium compounds on benzo(a) pyrene induced forestomach tumors and whole-blood glutathione peroxidase activities in C3H mice. Anticancer Res 6: 785-90.
4. Cameron R, Sweeney GD, Jones K, Lee G, Farber E (1976). A relative deficiency of Cytochrome P-450 and aryl hydrocarbon benzo(a)pyrene hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. Cancer Res 36: 3888-93.
5. Cekan E, Slanina P, Bergman K, Tribukait B (1985). Effect of dietary supplementation with selenomethionine on the teratogenic effect of isonising radiation in mice. Acta Radiol Oncol 24: 459-63.
6. Chiu DTY, Stults FH, Tappel A (1976). Purification and properties of rat lung soluble glutathione peroxidase. Biphys Biochim Acta 445: 558-66.
7. Combs GF Jr, Combs SB (1984). The nutritional biochemistry of selenium. Annu Rev Nutr 4: 257-80.
8. Combs GF Jr, Clark LC (1985). Can dietary selenium modify cancer risk? Nutr Rev 43: 335-41.
9. Cox DH, Bibb EA (1981). Hydrogen selenide evolution electrothermal atomic absorption method for determining nanogram levels of total selenium. J Assoc Off Anal Chem 64: 265-9.
10. Daoud AH, Griffin AC (1985). Effect of retinoic acid, butylated hydroxytoluene, propylgallate and selenium on 2-acetylaminofluorene induced hepatotoxicity. Cancer Lett 29: 183-88.
11. Dunnett CW (1955). A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50: 1096-121.
12. Dunnett CW (1964). New tables for multiple compariosn with a control. Biometrics 20: 482-92.
13. Epstein S, Ito N, Merkow LP, Farber E (1967). The cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism. Cancer Res 27: 1702-11.
14. Farber E (1980). The sequential analysis of liver cancer induction. Biophys Biochim Acta 605: 149-66.
15. Farber E (1984a). Precancerous steps in carcinogenesis - their physiological adaptive nature. Biophys Biochim Acta 138: 171-80.
16. Farber E (1984b). The biochemistry of preneoplastic liver: common metabolic pattern in hepatocyte nodules. Can J Biochem Cell Biol 64: 486-94.
17. Farber E (1990). Clonal adaptation during carcinogenesis. Biochem Pharmacol 39: 1837-46.
18. Farber E, Cameron R (1980). The sequential analysis of cancer development. Adv Cancer Res 35: 125-6.
19. Farber E, Hartman S, Gruenstein M (1976). The resistance of putative premalignant liver cell populations, hyperplastic nodules to the acute cytotoxic effects of some hepatocarcinogenesis. Cancer Res 36: 3879-87.
20. Ghosh B, Sardar S, Roy K, Chatterjee M (1995). Role of ß-carotene on the changes in activity patterns and levels of biotransforming enzymes in transplantable murine lymphoma. Cancer Lett 90: 191-7.
21. Guengerich EP (1988). Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 48: 2946-54.
22. Habig WH, Pabst MI, Jacoby WB (1974). Glutathione S-transferase: the first enzymatic step in marcapturic acid formation. Biol Chem 249: 7130-9.
23. Ip C (1981). Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res 41: 4386-90.
24. Ip C (1985). Selenium inhibition of chemical carcinogenesis. Fed Proc 44: 2573-8.
25. Jacobs MM, Forst C (1981). Toxicological effects of sodium selenite in Sprague Dawley rats. J Toxicol Environ Health 8: 575-85.
26. Jacobs MN, Janson B, Griffin AC (1977). Inhibitory effects of selenium on 1,2-dimethyl hydrazine and methylazoxymethanol acetate induction of colon tumours. Cancer Lett 2: 133-8.
27. Lillie RD (1954). Histopathological technique and practical histochemistry, 2nd Edition, New York, Blakiston.
28. Lowry GH, Rosebrough NJ, Farr AJ, Randall RL (1951). Protein measurement with folic phenol reagent. J Biol Chem 193: 265-75.
29. Medina D, Lane HW, Tracey CM (1983). Selenium and mouse mammary tumorigenesis: an investigation of possible mechanism. 43: 2460-4.
30. Moreno FS, Rizzi MBSL, Dagil MLZ, Penteado MVC (1991). Inhibitory effects of ß-carotene on preneoplastic lesions induced in wister rats by the resistant hepatocyte model. Carcinogenesis 12: 1817-22.
31. Ne've J (1991). Physiological and nutritional importance of selenium. Experentia 47: 187-93.
32. Omura T, Sato N (1964). The carbon monoxide binding pigment of liver microsomes. J Biol Chem 239: 2370-8.
33. Palmer IS, Olson OE (1974). Relative toxicities of selenite and selenate in the drinking water of rats. J Nutr 104: 306-14.
34. Poland A, Glover E (1973). Comparison of 2,3,7,8-tetra chlorodibenzodioxin, a potent inducer of aryl hydrocarbon hydroxylase with 3-methylcholanthrene. Mol Pharmacol 9: 736-47.
35. Sarkar A, Mukherjee B, Chatterjee M (1994). Inhibitory effect of β-carotene on 2-acetylaminofluorene-induced hepatocarcinogenesis in rat: reflection in hepatic drug metabolism. Carcinogenesis 15: 1055-60. Sato K (1990). Glutathione transferase as markers of preneoplasia and neoplasia. Adv Cancer Res 52: 205-5.
36. Sarkar A, Mukherjee B, Chatterjee M (1994). Inhibitory effect of β-carotene on 2-acetylaminofluorene-induced hepatocarcinogenesis in rat: reflection in hepatic drug metabolism. Carcinogenesis 15: 1055-60. Sato K (1990). Glutathione transferase as markers of preneoplasia and neoplasia. Adv Cancer Res 52: 205-5.
37. Scherer E (1984). Neoplastic progression in experimental hepatocarcinogenesis. Biophys Biochim Acta 738: 219-36.
38. Schroeder HA, Michener M (1971). Selenium and tellurium in rats: effect on growth, survival and tumors. J Nutr 101: 1531-40.
39. Shamberger RJ, Frost DV (1969). Possible protective effect of selenium against cancer. Can Med Assoc J 104: 686-7.
40. Thompson HJ, Becci PJ (1980). Selenium inhibition of N-methyl-N-nitrosourea induced mammary carcinogenesis in the rat. J Natl Cancer Inst 65: 1299-301.
41. Thompson JH, Meeker LD, Kokaska S (1984). Effect of an inorganic and organic form of dietary selenium on the promotional stage of mammary carcinogenesis in the rat. Cancer Res 44: 2803-6.
42. Vernie LN (1984). Selenium in carcinogenesis. Biophys Biochim Acta 738: 203-17.
43. World Health Organisation (1987). Selenium. WHO, Geneva, pp. 101-2.